Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol

International Journal of Pharmaceutics

Volumn 454, Issue 1, 2013, Pages 403-411

  Zhang, Yanzhuo ^a   Zhi, Zhizhuang ^b   Li, Xue ^b   Gao, Jian ^a   Song, Yaling ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Carboxylated ordered mesoporous carbon; Carvedilol; Crystalline state; Drug delivery; Poorly water soluble drugs

Indexed keywords

CARVEDILOL; DRUG CARRIER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 84884155673     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.07.009     Document Type: Article

References (51)

1. Ambrogi, V., Perioli, L., Marmottini, F., Giovagnoli, S., Esposito, M., Rossi, C., 2007. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. Eur. J. Pharm. Sci. 32, 216-222. (Pubitemid 47532714)
2. Barbé, C., Bartlett, J., Kong, L., Finnie, K., Lin, H.Q., Larkin, M., Calleja, S., Bush, A., Calleja, G., 2004. Silica particles: a novel drug-delivery system. Adv. Mater. 16, 1949-1966.
3. Cauda, V., Muhlstein, L., Onida, B., Bein, T., 2009. Tuning drug uptake and release rates through different morphologies and pore diameters of confined mesoporous silica. Microporous Mesoporous Mater. 118, 435-443.
4. Charnay, C., Bégu, S., Tourné-Péteilh, C., Nicole, L., Lerner, D.A., Devoisselle, J.M., 2004. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur. J. Pharm. Biopharm. 57, 533-540. (Pubitemid 38490572)
5. Chen, J.F., Ding, H.M., Wang, J.X., Shao, L., 2004. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25, 723-727. (Pubitemid 37357286)
6. Deng, X., Jia, G., Wang, H., Sun, H., Wang, X., Yang, S., Wang, T., Liu, Y., 2007. Translocation and fate of multi-walled carbon nanotubes in vivo. Carbon 46, 1419-1424. (Pubitemid 46829028)
7. Dunn, C.J., Lea, A.P., Wagstaff, A.J., 1997. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 54, 161-185. (Pubitemid 27300048)
8. Graeser, K.A., Strachan, C.J., Patterson, J.E., Gordon, K.C., Rades, T., 2008. Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin. Cryst. Growth Des. 8, 128-135.
9. Hartmann, M., Vinu, A., Chandrasekar, G., 2005. Adsorption of vitamin E on mesoporous carbon molecular sieves. Chem. Mater. 17, 829-833. (Pubitemid 40261336)
10. Heikkilä, T., Salonen, J., Tuura, J., Hamdy, M.S., Mul, G., Kumar, N., Salmi, T., Murzin, D.Y., Laitinen, L., Kaukonen, A.M., Hirvonen, J., Lehto, V.P., 2007. Mesoporous silica material TUD-1 as a drug delivery system. Int. J. Pharm. 331, 133-138. (Pubitemid 46176505)
11. Horcajada, P., Rámila, A., Pérez-Pariente, J., Vallet-Regi, M., 2004. Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater. 68, 105-109. (Pubitemid 38265756)
12. Hu, Y., Wang, J., Zhi, Z., Jiang, T., Wang, S., 2011. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J. Colloid Interface Sci. 363, 410-417.
13. Huanga, L.F., Tong, W.Q.T., 2004. Impact of solid state properties on developability assessment of drug candidates. Adv. Drug Deliv. Rev. 56, 321-334.
14. Kapoor, S., Hegde, R., Bhattacharyya, A.J., 2009. Influence of surface chemistry of mesoporous alumina with wide pore distribution on controlled drug release. J. Control Release 140, 34-39.
15. Kesisoglou, F., Panmai, S., Wu, Y., 2007. Nanosizing - oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59, 631-644. (Pubitemid 47285408)
16. Kim, T.W., Park, I.S., Ryoo, R., 2003. A synthetic route to ordered mesoporous carbon materials with graphitic pore walls. Angew. Chem. 115, 4511-4515.
17. Kim, T.W., Slowing, I.I., Chung, P.W., Lin, V.S.Y., 2011. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules. ACS Nano 5, 360-366.
18. Li, G.Y., Wang, P.M., Zhao, X., 2005. Mechanical behavior and microstructure of cement composites incorporating surface-treated multi-walled carbon nanotubes. Carbon 43, 1239-1245. (Pubitemid 40423363)
19. Liang, C.D., Li, Z.J., Dai, S., 2008. Mesoporous carbon materials: synthesis and modification. Angew. Chem. 47, 3696-3717.
20. Lipinski, C.A., 2002. Poor aqueous solubility - an industry wide problem in drug discovery. Am. Pharm. Rev. 53, 82-85.
21. Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting. Adv. Drug Deliv. Rev. 46, 3-26. (Pubitemid 33653411)
22. Liu, R., Shi, Y., Wan, Y., Meng, Y., Zhang, F., Gu, D., Chen, Z., Tu, B., Zhao, D., 2006. Triconstituent co-assembly to ordered mesostructured polymer-silica and carbon-silica nanocomposites and large-pore mesoporous carbons with high surface areas. J. Am. Chem. Soc. 128, 11652-11662. (Pubitemid 44338857)
23. Liu, R., Wang, X.Q., Zhao, X., Feng, P.Y., 2008. Sulfonated ordered mesoporous carbon for catalytic preparation of biodiesel. Carbon 46, 1664-1669.
24. Lu, A.H., Schmidt, W., Spliethoff, B., Schüth, F., 2003. Synthesis of ordered mesoporous carbon with bimodal pore system and high pore volume. Adv. Mater. 15, 1602-1606.
25. Mal, N.K., Fujiwara, M., Tanaka, Y., 2003. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 421, 350-353. (Pubitemid 36157928)
26. Mellaerts, R., Mols, R., Jammaer, J.A.G., Aerts, C.A., Annaert, P., Humbeeck, J.V., Mooter, G.V., Augustijns, P., Martens, J.A., 2008. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur. J. Pharm. Biopharm. 69, 223-230.
27. Pokharkar, V.B., Mandpe, L.P., Padamwar, M.N., Ambike, A.A., Mahadik, K.R., Paradkar, A., 2006. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol. 167, 20-25. (Pubitemid 44215984)
28. Salonen, J., Laitinen, L., Kaukonen, A.M., Tuura, J., Björkqvist, M., Heikkilä, T., Vähä-Heikkilä, K., Hirvonen, J., Lehto, V.P., 2005. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control Release 108, 362-374. (Pubitemid 41608668)
29. Sharma, P., Denny, W.A., Garg, S., 2009. Effect of wet milling process on the solid state of indomethacin and simvastatin. Int. J. Pharm. 380, 40-48.
30. Simovic, S., Heard, P., Hui, H., Song, Y., Peddie, F., Davey, A.K., Lewis, A., Rades, T., Prestidge, C.A., 2009. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Mol. Pharm. 6, 861-872.
31. Simovic, S., Hui, H., Song, Y., Davey, A.K., Rades, T., Prestidge, C.A., 2010. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles. J. Control Release 143, 367-373.
32. Slowing, I.I., Trewyn, B.G., Giri, S., Lin, V.S.Y., 2007. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Adv. Funct. Mater. 17, 1225-1236. (Pubitemid 46847636)
33. Speybroeck, M.V., Mols, R., Mellaerts, R., Thi, T.D., Martens, J.A., Humbeeckc, J.V., Annaerta, P., Mootera, G.V., Augustijnsa, P., 2010. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. Eur. J. Pharm. Biopharm. 75, 354-365.
34. Vallet-Regi, M., Balas, F., Arcos, D., 2007. Mesoporous materials for drug delivery. Angew. Chem. 47, 7548-7558. (Pubitemid 47556998)
35. Vasconcelos, T., Sarmento, B., Costa, P., 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 12, 1068-1075. (Pubitemid 350186132)
36. Vinu, A., Streb, C., Murugesan, V., Hartmann, M., 2003. Adsorption of cytochrome C on new mesoporous carbon molecular sieves. J. Phys. Chem. B 107, 8297-8299.
37. Thomas, M.J.K., Slipper, I., Walunj, A., Jain, A., Favretto, M.E., Kallinteri, P., Douroumis, D., 2009. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. Int. J. Pharm. 387, 272-277.
38. Wang, F., Hui, H., Barnes, T.J., Barnett, C., Prestidge, C.A., 2009. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol. Pharm. 7, 227-236.
39. Wang, S., 2009. Ordered mesoporous materials for drug delivery. Microporous Mesoporous Mater. 117, 1-9.
40. Wani, A., Muthuswamy, E., Layan Savithra, G.H., Mao, G., Brock, S., Oupický, D., 2012. Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone. Pharm. Res. 29, 2407-2418.
41. Wong, S.M., Kellaway, I.W., Murdan, S., 2006. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles. Int. J. Pharm. 317, 61-68. (Pubitemid 43866347)
42. Wu, C., Wang, Z., Zhi, Z., Jiang, T., Zhang, J., Wang, S., 2011. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs. Int. J. Pharm. 403, 162-169.
43. Xing, W., Qiao, S.Z., Ding, R.G., Li, F., Lu, G.Q., Yan, Z.F., Cheng, H.M., 2006. Superior electric double layer capacitors using ordered mesoporous carbons. Carbon 44, 216-224. (Pubitemid 41527834)
44. Yan, Y.D., Sung, J.H., Kim, K.K., Kim, D.W., Kim, J.O., Lee, B.J., Yong, C.S., Choi, H.G., 2012. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int. J. Pharm. 422, 202-210.
45. Yang, P.P., Quan, Z.W., Lu, L.L., Huang, S.S., Lin, J., 2008. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Biomaterials 29, 692-702. (Pubitemid 350181037)
46. Yu, H., Zhai, Q.Z., 2009. Mesoporous SBA-15 molecular sieve as a carrier for controlled release of nimodipine. Microporous Mesoporous Mater. 123, 298-305.
47. Yu, L., 2001. Amorphous pharmaceutical solids: preparation characterization and stabilization. Adv. Drug Deliv. Rev. 48, 27-42. (Pubitemid 32454482)
48. Zhang, F., Aaltonen, J., Tian, F., Saville, D.J., Rades, T., 2009. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin. Eur. J. Pharm. Biopharm. 71, 64-70.
49. Zhang, Y., Wang, J., Bai, X., Jiang, T., Zhang, Q., Wang, S., 2012. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol. Pharm. 9, 505-513.
50. Zhao, D.Y., Feng, J.L., Huo, Q.S., Melosh, N., Fredrickson, G.H., Chmelka, B.F., Stucky, G.D., 1998. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279, 548-552. (Pubitemid 28067280)
51. Zhao, J., Zhang, W., Sherrell, P., Razal, J.M., Huang, X., Minett, A.I., Chen, J., 2012. Carbon nanotube nanoweb-bioelectrode for highly selective dopamine sensing. Appl. Mater. Interfaces 4, 44-48